Formulation, Optimization, And Pharmacological Evaluation Of Macrophage Membrane-Camouflaged Redox-Sensitive Liposomes For Breast Cancer Theranostics
Background: Triple-negative breast cancer (TNBC) is an aggressive malignancy associated with limited targeted therapeutic options, high relapse rates, and considerable toxicity from conventional chemotherapy. Doxorubicin (DOX) remains an important therapeutic agent, but its clinical utility is limited by systemic toxic...